These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25575980)

  • 61. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
    Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma.
    Ekshyyan O; Rong Y; Rong X; Pattani KM; Abreo F; Caldito G; Chang JK; Ampil F; Glass J; Nathan CO
    Mol Cancer Ther; 2009 Aug; 8(8):2255-65. PubMed ID: 19625495
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Definitive chemoradiotherapy with carboplatin for squamous cell carcinoma of the head and neck.
    Nagasaka M; Zaki M; Issa M; Kim H; Abrams J; Sukari A
    Laryngoscope; 2017 Oct; 127(10):2260-2264. PubMed ID: 28271529
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation.
    Gannon OM; Merida de Long L; Endo-Munoz L; Hazar-Rethinam M; Saunders NA
    Clin Cancer Res; 2013 Jan; 19(2):428-41. PubMed ID: 23186778
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma.
    Tyagi A; Gu M; Takahata T; Frederick B; Agarwal C; Siriwardana S; Agarwal R; Sclafani RA
    Clin Cancer Res; 2011 Aug; 17(16):5402-11. PubMed ID: 21705453
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The antitumor drug F14512 enhances cisplatin and ionizing radiation effects in head and neck squamous carcinoma cell lines.
    Mouawad F; Gros A; Rysman B; Bal-Mahieu C; Bertheau C; Horn S; Sarrazin T; Lartigau E; Chevalier D; Bailly C; Lansiaux A; Meignan S
    Oral Oncol; 2014 Feb; 50(2):113-9. PubMed ID: 24290982
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cafestol, a coffee-specific diterpene, induces apoptosis in renal carcinoma Caki cells through down-regulation of anti-apoptotic proteins and Akt phosphorylation.
    Choi MJ; Park EJ; Oh JH; Min KJ; Yang ES; Kim YH; Lee TJ; Kim SH; Choi YH; Park JW; Kwon TK
    Chem Biol Interact; 2011 Apr; 190(2-3):102-8. PubMed ID: 21334318
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
    Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
    Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CHK1/2 Inhibitor Prexasertib Suppresses NOTCH Signaling and Enhances Cytotoxicity of Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma.
    Zeng L; Nikolaev A; Xing C; Della Manna DL; Yang ES
    Mol Cancer Ther; 2020 Jun; 19(6):1279-1288. PubMed ID: 32371584
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts.
    Baschnagel AM; Galoforo S; Thibodeau BJ; Ahmed S; Nirmal S; Akervall J; Wilson GD
    Anticancer Res; 2015 Nov; 35(11):5973-82. PubMed ID: 26504020
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma.
    Williams JP; Kim I; Ito E; Shi W; Yue S; Siu LL; Waldron J; O'Sullivan B; Yip KW; Liu FF
    PLoS One; 2014; 9(5):e98557. PubMed ID: 24853121
    [TBL] [Abstract][Full Text] [Related]  

  • 72. microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cɛ.
    Datta J; Smith A; Lang JC; Islam M; Dutt D; Teknos TN; Pan Q
    Oncogene; 2012 Sep; 31(36):4045-53. PubMed ID: 22158047
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines.
    Busch CJ; Becker B; Kriegs M; Gatzemeier F; Krüger K; Möckelmann N; Fritz G; Petersen C; Knecht R; Rothkamm K; Rieckmann T
    Oncotarget; 2016 Jun; 7(24):35832-35842. PubMed ID: 27127883
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cold atmospheric plasma treatment selectively targets head and neck squamous cell carcinoma cells.
    Guerrero-Preston R; Ogawa T; Uemura M; Shumulinsky G; Valle BL; Pirini F; Ravi R; Sidransky D; Keidar M; Trink B
    Int J Mol Med; 2014 Oct; 34(4):941-6. PubMed ID: 25050490
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sorafenib sensitizes head and neck squamous cell carcinoma cells to ionizing radiation.
    Laban S; Steinmeister L; Gleißner L; Grob TJ; Grénman R; Petersen C; Gal A; Knecht R; Dikomey E; Kriegs M
    Radiother Oncol; 2013 Nov; 109(2):286-92. PubMed ID: 23953412
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The impact of cumulative dose of cisplatin on outcome of patients with head and neck squamous cell carcinoma.
    Al-Mamgani A; de Ridder M; Navran A; Klop WM; de Boer JP; Tesselaar ME
    Eur Arch Otorhinolaryngol; 2017 Oct; 274(10):3757-3765. PubMed ID: 28755023
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Grape seed proanthocyanidins inhibit the invasive potential of head and neck cutaneous squamous cell carcinoma cells by targeting EGFR expression and epithelial-to-mesenchymal transition.
    Sun Q; Prasad R; Rosenthal E; Katiyar SK
    BMC Complement Altern Med; 2011 Dec; 11():134. PubMed ID: 22188922
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluating response to metformin/cisplatin combination in cancer cells via metabolic measurement and clonogenic survival.
    Woo SH; Sandulache VC; Yang L; Skinner HD
    Methods Mol Biol; 2014; 1165():11-8. PubMed ID: 24839015
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pre-radiation enhances the cytotoxicity of docetaxel in head and neck squamous cell carcinoma cells.
    Furuse S; Adachi M; Ijichi K; Ohta S; Torigoe S; Nakazawa M; Miura S; Mitsudo K; Tohnai I
    Oncol Rep; 2010 May; 23(5):1339-43. PubMed ID: 20372849
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
    Budach W; Bölke E; Kammers K; Gerber PA; Orth K; Gripp S; Matuschek C
    Radiother Oncol; 2016 Feb; 118(2):238-43. PubMed ID: 26589131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.